Honluten
Lung Extract Bioregulator · Pulmonary Cytomax · Хонлутен
Honluten is a lung-extract Cytomax-style SKU in Western catalogs. It is not one of the 21 names on the public e-peptide Cytomax poster (Taxorest is the bronchial-mucosa complex there). It is also not Chonluten, the lung/bronchi cytogen - the names collide on purpose in sloppy menus.
Use-case scores
0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.
- Immune2.5/10
Organ-map bronchial leaf. Confirm HPLC vs Chonluten (Glu-Asp-Gly). Not a COPD drug.
Compound card
- Class
- Khavinson-line bronchial peptide SKU (confirm vs Chonluten EDG)
- Formula
- Polypeptide extract (Lung tissue <10 kDa)
- Status
- Not FDA-approved · research use
How it works
Honluten is a Cytomax natural polypeptide extract from the lung and bronchial mucosa of young calves, delivering peptide signals to human alveolar type II pneumocytes, bronchial epithelial cells, and pulmonary interstitial cells to restore age-silenced gene expression governing surfactant production, mucociliary clearance, and alveolar repair capacity. It is the natural broad-spectrum lung extract counterpart to the targeted synthetic lung peptides Chonluten (Lys-Glu-Asp tripeptide) and Bronchogen (Ala-Glu-Asp-Leu tetrapeptide).
The lungs are one of the most metabolically exposed organs: over 10,000 liters of air pass through daily, delivering particulates, oxidants, pathogens, and irritants directly to the bronchial epithelium. Alveolar surface area declines ~4 m² per decade after age 30, and surfactant protein D (SP-D) production falls with age, reducing innate pathogen neutralization at the lung surface. Mucociliary clearance also slows, allowing inhaled particulates to accumulate in the small airways.
Honluten delivers short peptide signals (<10 kDa) from bovine lung/bronchial tissue to reactivate genes encoding: surfactant proteins B and D (SP-B, SP-D), CFTR (airway surface liquid maintenance), ciliogenesis factors (FOXJ1), and IL-10 (bronchial anti-inflammatory). Unlike Taxorest (A-19, which targets primarily bronchial mucosa), Honluten is sourced from both alveolar and bronchial components giving it a broader pulmonary coverage. In Khavinson's system, Honluten is used sequentially or in combination with Taxorest for enhanced respiratory recovery.
Source: PMID: 15677927
Khavinson map
Adjacent (not padded into the 41)Used in bioregulator stacks
Manufacturer-style organ combinations - not FDA protocols. Every name is a live leaf.
The Khavinson school
Vladimir Khatskelevich Khavinson (1946–2024) spent five decades at what became the St. Petersburg Institute of Bioregulation and Gerontology arguing a simple, stubborn idea: aging is, in part, a failure of tissue-specific peptide signals, and those signals can be restored. The first products were not “peptides” in the Instagram sense. They were Cytamins - polypeptide fractions isolated from a named organ of young animals. Later commercial refinements of those fractions are sold as Cytomaxes (Cytomed / NPCRIZ): still mixtures, still oral capsules, still defined by the source organ rather than a single sequence. When the group identified short active motifs inside those mixtures, they synthesized them as Cytogens - di-, tri-, and tetrapeptides with a one-letter code (KE, AEDG, KED, EDR, KEDP, and so on).
That three-layer stack is the whole map. Cytamin / pharmaceutical extracts (Thymalin, Epithalamin, Cortexin, Retinalamin, Prostatilen) are the clinic-era injectables registered in the former Soviet pharmacopeia. Cytomaxes are the capsule complexes Cytomed still lists as a 21-SKU organ line. Cytogens are the defined synthetics. English-language educators, including Brenden Henry’s public writing at Peptide Science Institute, add a further commercial distinction - later analog SKUs (N-acetyl, amidate, “V2” complexes) sold as more stable or more diverse than the original Cytomed lots. That last layer is a product taxonomy, not a Khavinson paper. We describe it so readers are not gaslit by three bottles with the same organ name. We do not reproduce paid Peptide Mastery protocols, Precision Cell Method language, or anyone else’s course IP.
Full Cytamin → Cytomax → Cytogen map, literature limits, and how we counted 41
The mechanism Khavinson published is epigenetic, not receptor-agonist in the GLP-1 sense. Short peptides are claimed to enter nuclei, interact with DNA/histones, and reopen tissue-specific transcription that condensed with age (heterochromatin → euchromatin). Reviews in the Bulletin of Experimental Biology and Medicine and Neuroendocrinology Letters (PMID 14523363, 15677927, 23888677) are the citable core. Complementary GI pharmacology is not mystical: di- and tripeptides are PEPT1/LAT substrates, which is why oral capsules are even a conversation. What is not established in Western Phase 3 programs is organ-by-organ disease treatment, telomere reversal as a clinical endpoint, or the manufacturer claim that Cytomax is “a third stronger” than Cytogen. Those are NPCRIZ marketing sentences.
Khavinson’s group published hundreds of papers, many in Russian, many in the same journal family. That is a real literature. It is also a literature with limited independent Western replication, small n, and a habit of using one review PMID as a stamp on every organ. On this site a leaf earns its organ story, its Cytomax↔Cytogen pair, its sequence if it has one, and an honest sentence about what has not been shown. Reconstitution math belongs on cytogens sold as vials. Cytomax capsules do not get a fake 5 mg vial.
The 41 we treat as canonical are the 21 Cytomaxes on the public e-peptide/Cytomed list, the 12 Cytogens on that same commercial line (including Vesilut, which Western catalogs often drop), plus eight historically load-bearing molecules that sit beside the capsule SKUs: Epitalon, Vilon, Thymogen, Livagen, Cortagen, Prostamax, Thymalin, and Epithalamin. Honluten, Cortexin, Retinalamin, Prostatilen, Thymulin, N-acetyl-epitalon-amidate, Pinalex, and the GPL Man / GPL Femme kits are covered as adjacent - same school or same storefront, not padded into a fake 41.
Public English-language teaching (including Brenden Henry at peptidescienceinstitute.com) is cited as context, not copied. Paid Peptide Mastery / Peptide Salvation text stays theirs.
History of this molecule
We keep Honluten because people search it and vendors sell it. The canonical 41 uses Taxorest for airway Cytomax. Honluten listings describe lung tissue extract as the “natural counterpart to Bronchogen.” Treat that as catalog language. Confirm the bottle: complex vs EDG cytogen vs bronchial mucosa.
Chonluten (cytogen, EDG) vs Honluten (extract SKU) is a one-letter disaster in search. Our leaves stay split.
Caveats
Lung Cytomax is not a US dietary-supplement monograph and not a drug. The tissue-extract model means lot-to-lot composition is a fingerprint, not a single CAS number. English-language “V2” bottles that claim more peptide diversity are a later commercial layer (mass-spec marketing from specific brands) - they are not Khavinson’s 1990s papers. Animal-source capsules are inappropriate if the reader has a religious or allergy constraint on the source species. None of this replaces care for the actual organ disease. Verify you did not buy Chonluten labeled Honluten.
Full 41-map: Khavinson bioregulators index · Bioregulator stacks
Research Use Cases
- ✓Lung Cytomax vs Bronchogen vs Chonluten
- ✓Not a chronic lung-condition treatment page
Dosing
| Phase | Dose | Frequency | Notes |
|---|---|---|---|
| Mini-Course / General Preventive (1 box) | 2 capsules (20 mg) | Once daily for 10 days, 30 min before meals | Standard Khavinson mini-course (20 caps). Repeat every 6 months. Combine with Taxorest (A-19) for comprehensive bronchial + alveolar lung coverage. |
| Full Monthly Course (Respiratory Recovery / Chronic Lung Support) | 2 capsules (20 mg) | Twice daily for 30 days (120 caps = 2× 60-cap boxes) | Bi-annual 30-day courses for post-COVID lung recovery, COPD stages I–II, or chronic bronchitis. Core pulmonary stack: Honluten + Taxorest (A-19) + Ventfort (A-3) for alveolar-bronchial-vascular lung health. |
| Intensive / Pulmonary Restoration Protocol | 2 capsules (20 mg) | Twice daily, repeated monthly | Post-pneumonia recovery, occupational lung exposure (silica, dust), or significant post-COVID lung remodeling. Physician supervision required. Max: 4 caps/day (40 mg). |
Administration
Honluten: Catalog lung capsule vs Not a research vial
- This is the real presentation: swallowed capsules. No reconstitution.
- Empty-stomach user-guide preference, same as other Cytomax boxes.
- Not a sublingual tablet. Nobody manufactures this SKU that way.
- Not in the canonical 41. Taxorest is the 21-list airway Cytomax.
- Lot fingerprint, animal source, no single CAS.
- Keep prescribed airway drugs. This is not a LABA.
- Refusing vial math on a capsule complex is the correct move.
- Forces the Chonluten vs Honluten spelling check before anyone mixes water.
- Not a COPD inhaler either way.
- Name collision with Chonluten (EDG cytogen) is a one-letter disaster.
- Chrome/vendor pages that print cytogen mg on this ID are the bug.
- Not on the e-peptide 21-poster. Adjacent, not a silent 22nd Cytomax.
Timeline
Who it is for
Post-COVID / Viral Pulmonary Recovery
LowTargets alveolar type II pneumocyte and bronchial epithelial gene expression. Addresses the mucosal and alveolar damage component of post-viral respiratory syndromes.
COPD / Chronic Bronchitis Support (Adjunct)
LowComplementary to standard COPD management. Works at the cellular gene program level to support bronchial mucosal integrity over time.
Safety & Considerations
Natural glandular extract (Cytomax) from bovine lung/bronchial tissue, <10 kDa. No hormones. Meets European/Russian veterinary standards. Generally recognized as safe.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Limits of current evidence
- English SKU names in this aisle collide. Sequence or do not dose.
Verdict
Honluten is a catalog spelling next to Chonluten. Confirm the one-letter sequence on the COA. Not a US pulmonary drug.
Interactions & Contraindications
This site will not treat COPD from a peptide page.
Synergies & Common Stacks
Complex vs bronchial cytogen.
Frequently Asked Questions
Oral capsule or injection?▼
Is Honluten in the 41?▼
Honluten vs Chonluten?▼
Vs Taxorest?▼
Reconstitution?▼
How does Honluten compare to Chonluten?▼
Why is Honluten separate from Taxorest (A-19)?▼
References
- Khavinson VKh et al. “Tissue-specific effects of peptides.” Bulletin of Experimental Biology and Medicine (2005). PMID: 15677927
- Khavinson VKh, Lin’kova NS, Tarnovskaya SI “Short peptides regulate gene expression.” Bulletin of Experimental Biology and Medicine (2013). PMID: 23888677
- Khavinson VKh, Morozov VG “Peptide regulation of aging: from experimental studies to clinical practice.” Advances in Gerontology (2003). PMID: 14523363
📚 Related Articles
Get Honluten from Vita-Stream - a distributor for Khavinson-line oral capsules. No reconstitution math on a Cytomax bottle.
Affiliate link · Full review